Award recordCONTRACT

VANDA PHARMACEUTICALS INC.

PIID 36C26025F0002· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $131,068 net obligations· UEI NG5JU1TQ3379· DC

Description

HETLIOZ - BULK

First action · last action
2024-10-01 · 2026-02-04
Transactions
2
First transaction's obligation
$162,771
Base + all options value (sum of deltas)
$131,068
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70102
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$162,771$0Base award · 2024-10-01 · this action $162,771 · running total $162,771Modification P00001 · 2026-02-04 · this action -$31,703 · running total $131,068
  • Base2024-10-01+$162,771= $162,771
  • Mod P000012026-02-04-$31,703= $131,068
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-10-01+$162,771$162,771HETLIOZ - BULK
Mod P00001· OTHER ADMINISTRATIVE ACTION2026-02-04−$31,703$131,068HETLIOZ - BULK

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NG5JU1TQ3379)

AwardOffice · PSC / listingNet obligationsFY
36C26026F0025260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$26,344FY2026
36E79724A0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36F79724D0191NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26024F0173260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$154,049FY2024
36C26023F0431260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$77,799FY2023
36E79722A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025F0002_3600_V797D70102_3600 · retrieved 2026-09-26.